Microdosing, a once somewhat niche practice, is slowly gaining momentum in the mainstream as the psychedelic renaissance continues to take shape. It’s often associated with psychedelics like LSD and ...
Body image can severely affect a person’s wellbeing, both physically and mentally, and researchers are close to understanding how psilocybin can help. Psilocybin’s effects on eating disorders (ED) ...
Unsupervised use of psilocybin, or “magic mushrooms,” has accelerated among all age groups in the United States, but especially among adolescents and people 30 and older, a new study found. “The ...
In April, Vail Health’s Behavioral Health Innovation Center will kick off the second of two studies aimed at targeting depression. The OPTIMIZE study will examine the impacts of psilocybin, the active ...
Psilocybin, the active psychedelic ingredient in magic mushrooms, has been proven to impact patients with depression positively. Vail Health’s OPTIMIZE study, which will administer doses of psilocybin ...
This is a small study, and scientists still need to conduct more research to understand the longterm effects of psilocybin. Psilocybin is the active ingredient in magic mushrooms. In recent decades, ...
Hosted on MSN
Psilocybin-assisted therapy linked to reduced depression in people with bipolar disorder, small study finds
A small pilot study published in the journal Psychedelic Medicine suggests that psilocybin-assisted psychotherapy might help reduce depressive symptoms in people with bipolar II disorder who have not ...
A new study at the University of Virginia is testing to see if a common recreational drug can help people cope with the loss of a loved one. Prolonged grief is a form of grief lasting for more than a ...
Richard Schaefer took part in a clinical trial of psilocybin as a treatment for addiction. (Photo courtesy of Richard Schaefer) It was a day like any other when Richard Schaefer entered a Madison ...
In a comparison of depression treatment trials, control group outcomes in trials of psilocybin were lower than those in trials of SSRIs and esketamine. This may suggest that psilocybin's ...
The present study consisted of 95 participants with alcohol use disorder who were randomized to receive either psilocybin or the antihistamine diphenhydramine. The study lasted 36 weeks, and the ...
Use of psilocybin, the hallucinogenic chemical found in what is known as "magic mushrooms," has increased significantly nationwide since 2019, according to a new study led by researchers at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results